nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Icatibant—ANPEP—hematologic cancer	0.0309	1	CrCbGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—LPAR1—hematologic cancer	0.0014	0.0146	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL17—hematologic cancer	0.00133	0.0139	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR5—hematologic cancer	0.0013	0.0136	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR7—hematologic cancer	0.00115	0.012	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL13—hematologic cancer	0.00115	0.012	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—TRH—hematologic cancer	0.00107	0.0112	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—LPAR1—hematologic cancer	0.00103	0.0108	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL17—hematologic cancer	0.00101	0.0106	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCR5—hematologic cancer	0.000991	0.0104	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—RASGRP1—hematologic cancer	0.00098	0.0103	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR2—hematologic cancer	0.000952	0.00997	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—hematologic cancer	0.000877	0.00919	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCR7—hematologic cancer	0.000875	0.00917	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL13—hematologic cancer	0.000875	0.00917	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—hematologic cancer	0.000819	0.00858	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—TRH—hematologic cancer	0.000813	0.00852	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GRB2—hematologic cancer	0.000789	0.00826	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—hematologic cancer	0.000788	0.00826	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—LPAR1—hematologic cancer	0.000788	0.00825	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CNR2—hematologic cancer	0.000725	0.0076	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—hematologic cancer	0.000696	0.00729	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—hematologic cancer	0.00068	0.00712	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RHOJ—hematologic cancer	0.000666	0.00698	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ARHGEF12—hematologic cancer	0.000652	0.00684	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ARHGEF1—hematologic cancer	0.000636	0.00666	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL3—hematologic cancer	0.000623	0.00653	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—PTHLH—hematologic cancer	0.000617	0.00646	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—PTGER4—hematologic cancer	0.0006	0.00629	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IFT172—hematologic cancer	0.000594	0.00622	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ARHGEF12—hematologic cancer	0.000593	0.00621	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ARHGEF1—hematologic cancer	0.000577	0.00605	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCR5—hematologic cancer	0.00056	0.00586	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PPEF1—hematologic cancer	0.000543	0.00569	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNA13—hematologic cancer	0.000541	0.00566	CbGpPWpGaD
Gonadorelin—Constipation—Vincristine—hematologic cancer	0.000535	0.000613	CcSEcCtD
Gonadorelin—Angiopathy—Dexamethasone—hematologic cancer	0.000533	0.00061	CcSEcCtD
Gonadorelin—Angiopathy—Betamethasone—hematologic cancer	0.000533	0.00061	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—TIAM1—hematologic cancer	0.000532	0.00557	CbGpPWpGaD
Gonadorelin—Pruritus—Bleomycin—hematologic cancer	0.000531	0.000608	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000531	0.000608	CcSEcCtD
Gonadorelin—Asthenia—Vinorelbine—hematologic cancer	0.00053	0.000607	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CXCR4—hematologic cancer	0.00053	0.00555	CbGpPWpGaD
Gonadorelin—Nausea—Vinblastine—hematologic cancer	0.000528	0.000605	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000526	0.000602	CcSEcCtD
Gonadorelin—Fatigue—Irinotecan—hematologic cancer	0.000525	0.000601	CcSEcCtD
Gonadorelin—Fatigue—Mitoxantrone—hematologic cancer	0.000525	0.000601	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000525	0.000601	CcSEcCtD
Gonadorelin—Vomiting—Lenalidomide—hematologic cancer	0.000523	0.000599	CcSEcCtD
Gonadorelin—Pruritus—Vinorelbine—hematologic cancer	0.000523	0.000598	CcSEcCtD
Gonadorelin—Breast disorder—Epirubicin—hematologic cancer	0.000522	0.000598	CcSEcCtD
Gonadorelin—Constipation—Irinotecan—hematologic cancer	0.000521	0.000597	CcSEcCtD
Gonadorelin—Pain—Irinotecan—hematologic cancer	0.000521	0.000597	CcSEcCtD
Gonadorelin—Pain—Mitoxantrone—hematologic cancer	0.000521	0.000597	CcSEcCtD
Gonadorelin—Constipation—Mitoxantrone—hematologic cancer	0.000521	0.000597	CcSEcCtD
Gonadorelin—Hypersensitivity—Thiotepa—hematologic cancer	0.00052	0.000595	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—hematologic cancer	0.00052	0.00545	CbGpPWpGaD
Gonadorelin—Abdominal pain—Carmustine—hematologic cancer	0.000518	0.000593	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CCL17—hematologic cancer	0.000518	0.00543	CbGpPWpGaD
Gonadorelin—Diarrhoea—Bortezomib—hematologic cancer	0.000518	0.000593	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—JAK3—hematologic cancer	0.000516	0.0054	CbGpPWpGaD
Gonadorelin—Vomiting—Hydroxyurea—hematologic cancer	0.000516	0.00059	CcSEcCtD
Gonadorelin—Headache—Lenalidomide—hematologic cancer	0.000515	0.00059	CcSEcCtD
Gonadorelin—Abdominal pain—Alitretinoin—hematologic cancer	0.000513	0.000588	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000513	0.000587	CcSEcCtD
Gonadorelin—Abdominal discomfort—Methotrexate—hematologic cancer	0.000512	0.000586	CcSEcCtD
Gonadorelin—Fatigue—Gemcitabine—hematologic cancer	0.000512	0.000586	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Vincristine—hematologic cancer	0.000512	0.000586	CcSEcCtD
Gonadorelin—Erythema—Dexamethasone—hematologic cancer	0.000511	0.000585	CcSEcCtD
Gonadorelin—Erythema—Betamethasone—hematologic cancer	0.000511	0.000585	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CXCR5—hematologic cancer	0.000508	0.00533	CbGpPWpGaD
Gonadorelin—Headache—Hydroxyurea—hematologic cancer	0.000508	0.000582	CcSEcCtD
Gonadorelin—Pain—Gemcitabine—hematologic cancer	0.000508	0.000581	CcSEcCtD
Gonadorelin—Constipation—Gemcitabine—hematologic cancer	0.000508	0.000581	CcSEcCtD
Gonadorelin—Abdominal pain—Ifosfamide—hematologic cancer	0.000507	0.000581	CcSEcCtD
Gonadorelin—Anaphylactic shock—Etoposide—hematologic cancer	0.000507	0.00058	CcSEcCtD
Gonadorelin—Asthenia—Thiotepa—hematologic cancer	0.000506	0.00058	CcSEcCtD
Gonadorelin—Diarrhoea—Vinorelbine—hematologic cancer	0.000506	0.000579	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—hematologic cancer	0.000504	0.00528	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Thalidomide—hematologic cancer	0.000503	0.000576	CcSEcCtD
Gonadorelin—Nausea—Melphalan—hematologic cancer	0.000502	0.000575	CcSEcCtD
Gonadorelin—Anaphylactic shock—Prednisolone—hematologic cancer	0.0005	0.000572	CcSEcCtD
Gonadorelin—Pruritus—Thiotepa—hematologic cancer	0.000499	0.000572	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000498	0.00057	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000498	0.00057	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Methotrexate—hematologic cancer	0.000496	0.000568	CcSEcCtD
Gonadorelin—Abdominal pain—Vincristine—hematologic cancer	0.000495	0.000566	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL13—hematologic cancer	0.000494	0.00518	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCR7—hematologic cancer	0.000494	0.00518	CbGpPWpGaD
Gonadorelin—Shock—Prednisolone—hematologic cancer	0.000492	0.000563	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—hematologic cancer	0.000491	0.00515	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PIK3R1—hematologic cancer	0.000491	0.00514	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNA13—hematologic cancer	0.000491	0.00514	CbGpPWpGaD
Gonadorelin—Asthenia—Thalidomide—hematologic cancer	0.00049	0.000561	CcSEcCtD
Gonadorelin—Nausea—Lenalidomide—hematologic cancer	0.000489	0.000559	CcSEcCtD
Gonadorelin—Breast disorder—Doxorubicin—hematologic cancer	0.000483	0.000553	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—TIAM1—hematologic cancer	0.000483	0.00506	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Carmustine—hematologic cancer	0.000483	0.000553	CcSEcCtD
Gonadorelin—Pruritus—Thalidomide—hematologic cancer	0.000483	0.000553	CcSEcCtD
Gonadorelin—Diarrhoea—Thiotepa—hematologic cancer	0.000483	0.000553	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—IL3RA—hematologic cancer	0.000482	0.00505	CbGpPWpGaD
Gonadorelin—Abdominal pain—Mitoxantrone—hematologic cancer	0.000482	0.000551	CcSEcCtD
Gonadorelin—Abdominal pain—Irinotecan—hematologic cancer	0.000482	0.000551	CcSEcCtD
Gonadorelin—Nausea—Hydroxyurea—hematologic cancer	0.000482	0.000551	CcSEcCtD
Gonadorelin—Vomiting—Bortezomib—hematologic cancer	0.000481	0.000551	CcSEcCtD
Gonadorelin—Hypersensitivity—Alitretinoin—hematologic cancer	0.000478	0.000548	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000478	0.000547	CcSEcCtD
Gonadorelin—Vomiting—Bleomycin—hematologic cancer	0.000478	0.000547	CcSEcCtD
Gonadorelin—Headache—Bortezomib—hematologic cancer	0.000474	0.000543	CcSEcCtD
Gonadorelin—Pain—Cisplatin—hematologic cancer	0.000473	0.000542	CcSEcCtD
Gonadorelin—Hypersensitivity—Ifosfamide—hematologic cancer	0.000473	0.000541	CcSEcCtD
Gonadorelin—Asthenia—Carmustine—hematologic cancer	0.00047	0.000538	CcSEcCtD
Gonadorelin—Vomiting—Vinorelbine—hematologic cancer	0.00047	0.000538	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—JAK3—hematologic cancer	0.000468	0.00491	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—hematologic cancer	0.000468	0.0049	CbGpPWpGaD
Gonadorelin—Diarrhoea—Thalidomide—hematologic cancer	0.000467	0.000535	CcSEcCtD
Gonadorelin—Asthenia—Alitretinoin—hematologic cancer	0.000466	0.000533	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—RGS2—hematologic cancer	0.000465	0.00487	CbGpPWpGaD
Gonadorelin—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000464	0.000532	CcSEcCtD
Gonadorelin—Angiopathy—Prednisone—hematologic cancer	0.000464	0.000531	CcSEcCtD
Gonadorelin—Headache—Vinorelbine—hematologic cancer	0.000463	0.00053	CcSEcCtD
Gonadorelin—Immune system disorder—Prednisone—hematologic cancer	0.000462	0.000529	CcSEcCtD
Gonadorelin—Hypersensitivity—Vincristine—hematologic cancer	0.000461	0.000528	CcSEcCtD
Gonadorelin—Asthenia—Ifosfamide—hematologic cancer	0.000461	0.000527	CcSEcCtD
Gonadorelin—Anaphylactic shock—Triamcinolone—hematologic cancer	0.00046	0.000526	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—TRH—hematologic cancer	0.00046	0.00482	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—TRIO—hematologic cancer	0.00046	0.00482	CbGpPWpGaD
Gonadorelin—Pruritus—Alitretinoin—hematologic cancer	0.000459	0.000526	CcSEcCtD
Gonadorelin—Pruritus—Ifosfamide—hematologic cancer	0.000454	0.00052	CcSEcCtD
Gonadorelin—Shock—Triamcinolone—hematologic cancer	0.000452	0.000518	CcSEcCtD
Gonadorelin—Nausea—Bortezomib—hematologic cancer	0.00045	0.000515	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL13—hematologic cancer	0.000449	0.0047	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCR7—hematologic cancer	0.000449	0.0047	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Irinotecan—hematologic cancer	0.000449	0.000514	CcSEcCtD
Gonadorelin—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000449	0.000514	CcSEcCtD
Gonadorelin—Asthenia—Vincristine—hematologic cancer	0.000449	0.000514	CcSEcCtD
Gonadorelin—Vomiting—Thiotepa—hematologic cancer	0.000449	0.000514	CcSEcCtD
Gonadorelin—Diarrhoea—Carmustine—hematologic cancer	0.000449	0.000513	CcSEcCtD
Gonadorelin—Nausea—Bleomycin—hematologic cancer	0.000446	0.000511	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—LPAR1—hematologic cancer	0.000445	0.00466	CbGpPWpGaD
Gonadorelin—Erythema—Prednisone—hematologic cancer	0.000445	0.00051	CcSEcCtD
Gonadorelin—Diarrhoea—Alitretinoin—hematologic cancer	0.000444	0.000509	CcSEcCtD
Gonadorelin—Headache—Thiotepa—hematologic cancer	0.000442	0.000506	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—hematologic cancer	0.000439	0.0046	CbGpPWpGaD
Gonadorelin—Diarrhoea—Ifosfamide—hematologic cancer	0.000439	0.000503	CcSEcCtD
Gonadorelin—Nausea—Vinorelbine—hematologic cancer	0.000439	0.000502	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000438	0.000501	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—IL3RA—hematologic cancer	0.000438	0.00458	CbGpPWpGaD
Gonadorelin—Asthenia—Irinotecan—hematologic cancer	0.000437	0.000501	CcSEcCtD
Gonadorelin—Asthenia—Mitoxantrone—hematologic cancer	0.000437	0.000501	CcSEcCtD
Gonadorelin—Fatigue—Etoposide—hematologic cancer	0.000437	0.0005	CcSEcCtD
Gonadorelin—Vomiting—Thalidomide—hematologic cancer	0.000434	0.000497	CcSEcCtD
Gonadorelin—Constipation—Etoposide—hematologic cancer	0.000434	0.000496	CcSEcCtD
Gonadorelin—Pain—Etoposide—hematologic cancer	0.000434	0.000496	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.00043	0.000492	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—HDAC11—hematologic cancer	0.000429	0.0045	CbGpPWpGaD
Gonadorelin—Diarrhoea—Vincristine—hematologic cancer	0.000428	0.00049	CcSEcCtD
Gonadorelin—Headache—Thalidomide—hematologic cancer	0.000428	0.000489	CcSEcCtD
Gonadorelin—Pain—Prednisolone—hematologic cancer	0.000428	0.000489	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—hematologic cancer	0.000427	0.00447	CbGpPWpGaD
Gonadorelin—Asthenia—Gemcitabine—hematologic cancer	0.000426	0.000488	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—RGS2—hematologic cancer	0.000422	0.00442	CbGpPWpGaD
Gonadorelin—Pruritus—Gemcitabine—hematologic cancer	0.00042	0.000481	CcSEcCtD
Gonadorelin—Nausea—Thiotepa—hematologic cancer	0.000419	0.00048	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—TRH—hematologic cancer	0.000417	0.00437	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—TRIO—hematologic cancer	0.000417	0.00437	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000417	0.000478	CcSEcCtD
Gonadorelin—Anaphylactic shock—Betamethasone—hematologic cancer	0.000417	0.000478	CcSEcCtD
Gonadorelin—Diarrhoea—Irinotecan—hematologic cancer	0.000417	0.000477	CcSEcCtD
Gonadorelin—Diarrhoea—Mitoxantrone—hematologic cancer	0.000417	0.000477	CcSEcCtD
Gonadorelin—Vomiting—Carmustine—hematologic cancer	0.000417	0.000477	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Etoposide—hematologic cancer	0.000415	0.000475	CcSEcCtD
Gonadorelin—Vomiting—Alitretinoin—hematologic cancer	0.000413	0.000473	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—BCR—hematologic cancer	0.000412	0.00431	CbGpPWpGaD
Gonadorelin—Headache—Carmustine—hematologic cancer	0.000411	0.00047	CcSEcCtD
Gonadorelin—Shock—Dexamethasone—hematologic cancer	0.00041	0.00047	CcSEcCtD
Gonadorelin—Shock—Betamethasone—hematologic cancer	0.00041	0.00047	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CNR2—hematologic cancer	0.00041	0.00429	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PDE4B—hematologic cancer	0.00041	0.00429	CbGpPWpGaD
Gonadorelin—Nervous system disorder—Dexamethasone—hematologic cancer	0.000409	0.000468	CcSEcCtD
Gonadorelin—Nervous system disorder—Betamethasone—hematologic cancer	0.000409	0.000468	CcSEcCtD
Gonadorelin—Vomiting—Ifosfamide—hematologic cancer	0.000408	0.000467	CcSEcCtD
Gonadorelin—Hypersensitivity—Cisplatin—hematologic cancer	0.000408	0.000467	CcSEcCtD
Gonadorelin—Headache—Alitretinoin—hematologic cancer	0.000407	0.000466	CcSEcCtD
Gonadorelin—Diarrhoea—Gemcitabine—hematologic cancer	0.000406	0.000465	CcSEcCtD
Gonadorelin—Nausea—Thalidomide—hematologic cancer	0.000405	0.000464	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—LPAR1—hematologic cancer	0.000404	0.00424	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—RAC2—hematologic cancer	0.000403	0.00422	CbGpPWpGaD
Gonadorelin—Abdominal pain—Etoposide—hematologic cancer	0.000401	0.000459	CcSEcCtD
Gonadorelin—Vomiting—Vincristine—hematologic cancer	0.000398	0.000455	CcSEcCtD
Gonadorelin—Asthenia—Cisplatin—hematologic cancer	0.000397	0.000454	CcSEcCtD
Gonadorelin—Fatigue—Triamcinolone—hematologic cancer	0.000396	0.000454	CcSEcCtD
Gonadorelin—Pain—Triamcinolone—hematologic cancer	0.000393	0.00045	CcSEcCtD
Gonadorelin—Headache—Vincristine—hematologic cancer	0.000392	0.000449	CcSEcCtD
Gonadorelin—Nausea—Carmustine—hematologic cancer	0.000389	0.000446	CcSEcCtD
Gonadorelin—Angiopathy—Methotrexate—hematologic cancer	0.000388	0.000444	CcSEcCtD
Gonadorelin—Vomiting—Mitoxantrone—hematologic cancer	0.000388	0.000444	CcSEcCtD
Gonadorelin—Vomiting—Irinotecan—hematologic cancer	0.000388	0.000444	CcSEcCtD
Gonadorelin—Immune system disorder—Methotrexate—hematologic cancer	0.000386	0.000442	CcSEcCtD
Gonadorelin—Nausea—Alitretinoin—hematologic cancer	0.000386	0.000442	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—ADCY7—hematologic cancer	0.000385	0.00404	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HDAC10—hematologic cancer	0.000383	0.00401	CbGpPWpGaD
Gonadorelin—Headache—Mitoxantrone—hematologic cancer	0.000382	0.000437	CcSEcCtD
Gonadorelin—Headache—Irinotecan—hematologic cancer	0.000382	0.000437	CcSEcCtD
Gonadorelin—Nausea—Ifosfamide—hematologic cancer	0.000381	0.000436	CcSEcCtD
Gonadorelin—Diarrhoea—Cisplatin—hematologic cancer	0.000379	0.000433	CcSEcCtD
Gonadorelin—Vomiting—Gemcitabine—hematologic cancer	0.000377	0.000432	CcSEcCtD
Gonadorelin—Hypersensitivity—Etoposide—hematologic cancer	0.000373	0.000428	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PDE4B—hematologic cancer	0.000372	0.0039	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CNR2—hematologic cancer	0.000372	0.0039	CbGpPWpGaD
Gonadorelin—Erythema—Methotrexate—hematologic cancer	0.000372	0.000426	CcSEcCtD
Gonadorelin—Headache—Gemcitabine—hematologic cancer	0.000372	0.000426	CcSEcCtD
Gonadorelin—Nausea—Vincristine—hematologic cancer	0.000372	0.000425	CcSEcCtD
Gonadorelin—Hypersensitivity—Prednisolone—hematologic cancer	0.000368	0.000422	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—RAC2—hematologic cancer	0.000366	0.00383	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	0.000365	0.00382	CbGpPWpGaD
Gonadorelin—Asthenia—Etoposide—hematologic cancer	0.000364	0.000416	CcSEcCtD
Gonadorelin—Anaphylactic shock—Prednisone—hematologic cancer	0.000363	0.000416	CcSEcCtD
Gonadorelin—Angiopathy—Epirubicin—hematologic cancer	0.000363	0.000415	CcSEcCtD
Gonadorelin—Nausea—Mitoxantrone—hematologic cancer	0.000362	0.000414	CcSEcCtD
Gonadorelin—Nausea—Irinotecan—hematologic cancer	0.000362	0.000414	CcSEcCtD
Gonadorelin—Immune system disorder—Epirubicin—hematologic cancer	0.000361	0.000414	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.00036	0.000412	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.00036	0.000412	CcSEcCtD
Gonadorelin—Fatigue—Betamethasone—hematologic cancer	0.00036	0.000412	CcSEcCtD
Gonadorelin—Fatigue—Dexamethasone—hematologic cancer	0.00036	0.000412	CcSEcCtD
Gonadorelin—Pruritus—Etoposide—hematologic cancer	0.000359	0.000411	CcSEcCtD
Gonadorelin—Shock—Prednisone—hematologic cancer	0.000357	0.000409	CcSEcCtD
Gonadorelin—Pain—Dexamethasone—hematologic cancer	0.000357	0.000408	CcSEcCtD
Gonadorelin—Pain—Betamethasone—hematologic cancer	0.000357	0.000408	CcSEcCtD
Gonadorelin—Nervous system disorder—Prednisone—hematologic cancer	0.000356	0.000408	CcSEcCtD
Gonadorelin—Nausea—Gemcitabine—hematologic cancer	0.000353	0.000404	CcSEcCtD
Gonadorelin—Vomiting—Cisplatin—hematologic cancer	0.000352	0.000403	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ARHGEF12—hematologic cancer	0.00035	0.00367	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADCY7—hematologic cancer	0.00035	0.00366	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PTHLH—hematologic cancer	0.000348	0.00365	CbGpPWpGaD
Gonadorelin—Erythema—Epirubicin—hematologic cancer	0.000348	0.000399	CcSEcCtD
Gonadorelin—Diarrhoea—Etoposide—hematologic cancer	0.000347	0.000397	CcSEcCtD
Gonadorelin—Flatulence—Epirubicin—hematologic cancer	0.000343	0.000393	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000341	0.000391	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000341	0.000391	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ARHGEF1—hematologic cancer	0.000341	0.00357	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PTGER4—hematologic cancer	0.000339	0.00355	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Triamcinolone—hematologic cancer	0.000339	0.000388	CcSEcCtD
Gonadorelin—Angiopathy—Doxorubicin—hematologic cancer	0.000336	0.000384	CcSEcCtD
Gonadorelin—Immune system disorder—Doxorubicin—hematologic cancer	0.000334	0.000383	CcSEcCtD
Gonadorelin—Asthenia—Triamcinolone—hematologic cancer	0.00033	0.000378	CcSEcCtD
Gonadorelin—Abdominal pain—Betamethasone—hematologic cancer	0.00033	0.000378	CcSEcCtD
Gonadorelin—Abdominal pain—Dexamethasone—hematologic cancer	0.00033	0.000378	CcSEcCtD
Gonadorelin—Nausea—Cisplatin—hematologic cancer	0.000329	0.000376	CcSEcCtD
Gonadorelin—Pruritus—Triamcinolone—hematologic cancer	0.000325	0.000372	CcSEcCtD
Gonadorelin—Vomiting—Etoposide—hematologic cancer	0.000322	0.000369	CcSEcCtD
Gonadorelin—Erythema—Doxorubicin—hematologic cancer	0.000322	0.000369	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CCL3—hematologic cancer	0.00032	0.00335	CbGpPWpGaD
Gonadorelin—Headache—Etoposide—hematologic cancer	0.000318	0.000364	CcSEcCtD
Gonadorelin—Flatulence—Doxorubicin—hematologic cancer	0.000317	0.000363	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PTHLH—hematologic cancer	0.000316	0.00331	CbGpPWpGaD
Gonadorelin—Fatigue—Prednisone—hematologic cancer	0.000313	0.000359	CcSEcCtD
Gonadorelin—Headache—Prednisolone—hematologic cancer	0.000313	0.000359	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—hematologic cancer	0.000313	0.00327	CbGpPWpGaD
Gonadorelin—Constipation—Prednisone—hematologic cancer	0.000311	0.000356	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PTGER4—hematologic cancer	0.000308	0.00323	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AGRN—hematologic cancer	0.000306	0.0032	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL17—hematologic cancer	0.000306	0.0032	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Methotrexate—hematologic cancer	0.000304	0.000348	CcSEcCtD
Gonadorelin—Nausea—Etoposide—hematologic cancer	0.000301	0.000345	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CXCR5—hematologic cancer	0.0003	0.00315	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCR4—hematologic cancer	0.0003	0.00314	CbGpPWpGaD
Gonadorelin—Asthenia—Betamethasone—hematologic cancer	0.000299	0.000343	CcSEcCtD
Gonadorelin—Asthenia—Dexamethasone—hematologic cancer	0.000299	0.000343	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	0.000299	0.00314	CbGpPWpGaD
Gonadorelin—Nervous system disorder—Methotrexate—hematologic cancer	0.000298	0.000341	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Prednisone—hematologic cancer	0.000297	0.00034	CcSEcCtD
Gonadorelin—Nausea—Prednisolone—hematologic cancer	0.000297	0.00034	CcSEcCtD
Gonadorelin—Pruritus—Dexamethasone—hematologic cancer	0.000295	0.000338	CcSEcCtD
Gonadorelin—Pruritus—Betamethasone—hematologic cancer	0.000295	0.000338	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—LEF1—hematologic cancer	0.000295	0.00309	CbGpPWpGaD
Gonadorelin—Vomiting—Triamcinolone—hematologic cancer	0.000292	0.000335	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—GNA13—hematologic cancer	0.00029	0.00304	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—IL3—hematologic cancer	0.000289	0.00303	CbGpPWpGaD
Gonadorelin—Headache—Triamcinolone—hematologic cancer	0.000288	0.00033	CcSEcCtD
Gonadorelin—Abdominal pain—Prednisone—hematologic cancer	0.000287	0.000329	CcSEcCtD
Gonadorelin—Diarrhoea—Dexamethasone—hematologic cancer	0.000285	0.000327	CcSEcCtD
Gonadorelin—Diarrhoea—Betamethasone—hematologic cancer	0.000285	0.000327	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—TIAM1—hematologic cancer	0.000285	0.00299	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Epirubicin—hematologic cancer	0.000284	0.000325	CcSEcCtD
Gonadorelin—Shock—Epirubicin—hematologic cancer	0.00028	0.00032	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—RASGRP1—hematologic cancer	0.000279	0.00293	CbGpPWpGaD
Gonadorelin—Nervous system disorder—Epirubicin—hematologic cancer	0.000279	0.000319	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL2—hematologic cancer	0.000278	0.00291	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—JAK3—hematologic cancer	0.000277	0.0029	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PIK3CA—hematologic cancer	0.000276	0.00289	CbGpPWpGaD
Gonadorelin—Nausea—Triamcinolone—hematologic cancer	0.000273	0.000313	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CXCR4—hematologic cancer	0.000272	0.00285	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	0.000269	0.00282	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Prednisone—hematologic cancer	0.000268	0.000306	CcSEcCtD
Gonadorelin—Vomiting—Betamethasone—hematologic cancer	0.000265	0.000304	CcSEcCtD
Gonadorelin—Vomiting—Dexamethasone—hematologic cancer	0.000265	0.000304	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CXCL13—hematologic cancer	0.000265	0.00278	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCR7—hematologic cancer	0.000265	0.00278	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000263	0.000301	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—IL3—hematologic cancer	0.000262	0.00275	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000262	0.0003	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—NCOR2—hematologic cancer	0.000262	0.00274	CbGpPWpGaD
Gonadorelin—Fatigue—Methotrexate—hematologic cancer	0.000262	0.0003	CcSEcCtD
Gonadorelin—Headache—Betamethasone—hematologic cancer	0.000261	0.000299	CcSEcCtD
Gonadorelin—Headache—Dexamethasone—hematologic cancer	0.000261	0.000299	CcSEcCtD
Gonadorelin—Asthenia—Prednisone—hematologic cancer	0.000261	0.000298	CcSEcCtD
Gonadorelin—Pain—Methotrexate—hematologic cancer	0.00026	0.000297	CcSEcCtD
Gonadorelin—Shock—Doxorubicin—hematologic cancer	0.000259	0.000296	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—IL3RA—hematologic cancer	0.000259	0.00271	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CRKL—hematologic cancer	0.000259	0.00271	CbGpPWpGaD
Gonadorelin—Nervous system disorder—Doxorubicin—hematologic cancer	0.000258	0.000295	CcSEcCtD
Gonadorelin—Pruritus—Prednisone—hematologic cancer	0.000257	0.000294	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—RASGRP1—hematologic cancer	0.000254	0.00266	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GRB2—hematologic cancer	0.000251	0.00263	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RGS2—hematologic cancer	0.000249	0.00261	CbGpPWpGaD
Gonadorelin—Diarrhoea—Prednisone—hematologic cancer	0.000249	0.000285	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000248	0.000284	CcSEcCtD
Gonadorelin—Nausea—Betamethasone—hematologic cancer	0.000248	0.000284	CcSEcCtD
Gonadorelin—Nausea—Dexamethasone—hematologic cancer	0.000248	0.000284	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	0.000247	0.00259	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TRIO—hematologic cancer	0.000247	0.00258	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TRH—hematologic cancer	0.000247	0.00258	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CMA1—hematologic cancer	0.000247	0.00258	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000245	0.000281	CcSEcCtD
Gonadorelin—Fatigue—Epirubicin—hematologic cancer	0.000245	0.00028	CcSEcCtD
Gonadorelin—Pain—Epirubicin—hematologic cancer	0.000243	0.000278	CcSEcCtD
Gonadorelin—Constipation—Epirubicin—hematologic cancer	0.000243	0.000278	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—AGO2—hematologic cancer	0.000241	0.00253	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SPHK1—hematologic cancer	0.000241	0.00253	CbGpPWpGaD
Gonadorelin—Abdominal pain—Methotrexate—hematologic cancer	0.00024	0.000275	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—HDAC9—hematologic cancer	0.000239	0.0025	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LPAR1—hematologic cancer	0.000239	0.0025	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—H3F3B—hematologic cancer	0.000236	0.00248	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000232	0.000266	CcSEcCtD
Gonadorelin—Vomiting—Prednisone—hematologic cancer	0.000231	0.000264	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	0.000229	0.0024	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GRB2—hematologic cancer	0.000228	0.00239	CbGpPWpGaD
Gonadorelin—Headache—Prednisone—hematologic cancer	0.000228	0.000261	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000227	0.00026	CcSEcCtD
Gonadorelin—Fatigue—Doxorubicin—hematologic cancer	0.000227	0.000259	CcSEcCtD
Gonadorelin—Constipation—Doxorubicin—hematologic cancer	0.000225	0.000257	CcSEcCtD
Gonadorelin—Pain—Doxorubicin—hematologic cancer	0.000225	0.000257	CcSEcCtD
Gonadorelin—Abdominal pain—Epirubicin—hematologic cancer	0.000225	0.000257	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CSF2—hematologic cancer	0.000225	0.00235	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Methotrexate—hematologic cancer	0.000224	0.000256	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—PDE4B—hematologic cancer	0.00022	0.0023	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CNR2—hematologic cancer	0.00022	0.0023	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	0.000219	0.00229	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF19—hematologic cancer	0.000218	0.00228	CbGpPWpGaD
Gonadorelin—Asthenia—Methotrexate—hematologic cancer	0.000218	0.000249	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCG—hematologic cancer	0.000217	0.00227	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—JAK1—hematologic cancer	0.000217	0.00227	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RAC2—hematologic cancer	0.000216	0.00227	CbGpPWpGaD
Gonadorelin—Nausea—Prednisone—hematologic cancer	0.000216	0.000247	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000215	0.000246	CcSEcCtD
Gonadorelin—Pruritus—Methotrexate—hematologic cancer	0.000215	0.000246	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—DKK1—hematologic cancer	0.000215	0.00225	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT5B—hematologic cancer	0.000213	0.00223	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Epirubicin—hematologic cancer	0.000209	0.00024	CcSEcCtD
Gonadorelin—Abdominal pain—Doxorubicin—hematologic cancer	0.000208	0.000238	CcSEcCtD
Gonadorelin—Diarrhoea—Methotrexate—hematologic cancer	0.000208	0.000238	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ADCY7—hematologic cancer	0.000207	0.00216	CbGpPWpGaD
Gonadorelin—Asthenia—Epirubicin—hematologic cancer	0.000204	0.000233	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CSF2—hematologic cancer	0.000204	0.00214	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—IL2RA—hematologic cancer	0.000202	0.00212	CbGpPWpGaD
Gonadorelin—Pruritus—Epirubicin—hematologic cancer	0.000201	0.00023	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—XIAP—hematologic cancer	0.000201	0.00211	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—JAK1—hematologic cancer	0.000197	0.00206	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCG—hematologic cancer	0.000197	0.00206	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SH2B3—hematologic cancer	0.000196	0.00205	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SMARCA4—hematologic cancer	0.000196	0.00205	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GZMB—hematologic cancer	0.000195	0.00204	CbGpPWpGaD
Gonadorelin—Diarrhoea—Epirubicin—hematologic cancer	0.000194	0.000223	CcSEcCtD
Gonadorelin—Hypersensitivity—Doxorubicin—hematologic cancer	0.000194	0.000222	CcSEcCtD
Gonadorelin—Vomiting—Methotrexate—hematologic cancer	0.000193	0.000221	CcSEcCtD
Gonadorelin—Headache—Methotrexate—hematologic cancer	0.00019	0.000218	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CTNNA1—hematologic cancer	0.00019	0.00199	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000189	0.00198	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL3—hematologic cancer	0.000189	0.00198	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HSPB1—hematologic cancer	0.000189	0.00198	CbGpPWpGaD
Gonadorelin—Asthenia—Doxorubicin—hematologic cancer	0.000189	0.000216	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—PTHLH—hematologic cancer	0.000187	0.00196	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SDC1—hematologic cancer	0.000187	0.00196	CbGpPWpGaD
Gonadorelin—Pruritus—Doxorubicin—hematologic cancer	0.000186	0.000213	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—IL2RA—hematologic cancer	0.000184	0.00193	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTGER4—hematologic cancer	0.000182	0.00191	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LCK—hematologic cancer	0.000181	0.0019	CbGpPWpGaD
Gonadorelin—Vomiting—Epirubicin—hematologic cancer	0.000181	0.000207	CcSEcCtD
Gonadorelin—Nausea—Methotrexate—hematologic cancer	0.00018	0.000206	CcSEcCtD
Gonadorelin—Diarrhoea—Doxorubicin—hematologic cancer	0.00018	0.000206	CcSEcCtD
Gonadorelin—Headache—Epirubicin—hematologic cancer	0.000178	0.000204	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—H3F3A—hematologic cancer	0.000177	0.00186	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCZ—hematologic cancer	0.000172	0.00181	CbGpPWpGaD
Gonadorelin—Nausea—Epirubicin—hematologic cancer	0.000169	0.000193	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000169	0.00177	CbGpPWpGaD
Gonadorelin—Vomiting—Doxorubicin—hematologic cancer	0.000167	0.000191	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—PARP1—hematologic cancer	0.000167	0.00175	CbGpPWpGaD
Gonadorelin—Headache—Doxorubicin—hematologic cancer	0.000165	0.000189	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—FBXW7—hematologic cancer	0.000164	0.00172	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCR4—hematologic cancer	0.000161	0.00168	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HDAC2—hematologic cancer	0.000161	0.00168	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CBL—hematologic cancer	0.000157	0.00164	CbGpPWpGaD
Gonadorelin—Nausea—Doxorubicin—hematologic cancer	0.000156	0.000179	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—IL3—hematologic cancer	0.000155	0.00162	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CG—hematologic cancer	0.000153	0.0016	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTPN1—hematologic cancer	0.000152	0.0016	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PTPN11—hematologic cancer	0.00015	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RASGRP1—hematologic cancer	0.00015	0.00157	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SYK—hematologic cancer	0.000149	0.00157	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HSP90AA1—hematologic cancer	0.000149	0.00157	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000148	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CREB1—hematologic cancer	0.000146	0.00153	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT1—hematologic cancer	0.000144	0.00151	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL2—hematologic cancer	0.000143	0.00149	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6R—hematologic cancer	0.000142	0.00149	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3R1—hematologic cancer	0.00014	0.00147	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—JAK2—hematologic cancer	0.000136	0.00142	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAP2K1—hematologic cancer	0.000135	0.00142	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GRB2—hematologic cancer	0.000135	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CD—hematologic cancer	0.000135	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDGFA—hematologic cancer	0.000134	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KITLG—hematologic cancer	0.000133	0.00139	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT5A—hematologic cancer	0.00013	0.00136	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000129	0.00135	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CDKN2B—hematologic cancer	0.000128	0.00135	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3R1—hematologic cancer	0.000127	0.00133	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CD86—hematologic cancer	0.000124	0.0013	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—JAK2—hematologic cancer	0.000124	0.00129	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HES1—hematologic cancer	0.000123	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NCOR1—hematologic cancer	0.000122	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF1—hematologic cancer	0.00012	0.00126	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CSF2—hematologic cancer	0.00012	0.00126	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FOXO1—hematologic cancer	0.000119	0.00124	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—IL2—hematologic cancer	0.000119	0.00124	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDGFRB—hematologic cancer	0.000118	0.00124	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CB—hematologic cancer	0.000117	0.00123	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDGFRA—hematologic cancer	0.000117	0.00122	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—JAK1—hematologic cancer	0.000116	0.00122	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCG—hematologic cancer	0.000116	0.00122	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL2RA—hematologic cancer	0.000109	0.00114	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL2—hematologic cancer	0.000108	0.00113	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TERT—hematologic cancer	0.000107	0.00112	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDGFB—hematologic cancer	0.000105	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TSC2—hematologic cancer	0.000102	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGFR3—hematologic cancer	9.85e-05	0.00103	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK14—hematologic cancer	9.75e-05	0.00102	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ESR1—hematologic cancer	9.57e-05	0.001	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FN1—hematologic cancer	9.45e-05	0.00099	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BAD—hematologic cancer	9.34e-05	0.000978	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NFKBIA—hematologic cancer	9.34e-05	0.000978	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NOTCH1—hematologic cancer	9.25e-05	0.000969	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CD80—hematologic cancer	9.06e-05	0.000949	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CG—hematologic cancer	9.04e-05	0.000947	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KIT—hematologic cancer	9.04e-05	0.000947	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NRAS—hematologic cancer	9.04e-05	0.000947	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTPN11—hematologic cancer	8.89e-05	0.000931	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAPK3—hematologic cancer	8.66e-05	0.000907	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CREB1—hematologic cancer	8.61e-05	0.000902	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BRAF—hematologic cancer	8.5e-05	0.000891	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL2—hematologic cancer	8.42e-05	0.000882	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6R—hematologic cancer	8.4e-05	0.00088	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CREBBP—hematologic cancer	8.39e-05	0.000878	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAP2K1—hematologic cancer	8e-05	0.000838	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CD—hematologic cancer	7.95e-05	0.000833	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CA—hematologic cancer	7.88e-05	0.000825	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—KRAS—hematologic cancer	7.78e-05	0.000815	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF2—hematologic cancer	7.61e-05	0.000797	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3R1—hematologic cancer	7.51e-05	0.000786	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—JAK2—hematologic cancer	7.3e-05	0.000764	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CA—hematologic cancer	7.15e-05	0.000749	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MDM2—hematologic cancer	7.12e-05	0.000746	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CB—hematologic cancer	6.93e-05	0.000726	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MTOR—hematologic cancer	6.93e-05	0.000726	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HRAS—hematologic cancer	6.62e-05	0.000693	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CDKN1B—hematologic cancer	6.5e-05	0.000681	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT1—hematologic cancer	6.43e-05	0.000674	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CASP3—hematologic cancer	6.37e-05	0.000668	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL2—hematologic cancer	6.36e-05	0.000667	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—hematologic cancer	6.33e-05	0.000663	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCND1—hematologic cancer	6.2e-05	0.00065	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—JUN—hematologic cancer	6.19e-05	0.000649	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CDKN1A—hematologic cancer	6e-05	0.000629	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTEN—hematologic cancer	5.99e-05	0.000627	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK8—hematologic cancer	5.86e-05	0.000614	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT1—hematologic cancer	5.84e-05	0.000612	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EP300—hematologic cancer	5.71e-05	0.000598	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SRC—hematologic cancer	5.55e-05	0.000582	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VEGFA—hematologic cancer	5.41e-05	0.000567	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT3—hematologic cancer	5.36e-05	0.000561	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NRAS—hematologic cancer	5.34e-05	0.00056	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK3—hematologic cancer	5.12e-05	0.000536	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MYC—hematologic cancer	4.98e-05	0.000521	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TGFB1—hematologic cancer	4.96e-05	0.00052	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KRAS—hematologic cancer	4.6e-05	0.000482	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CA—hematologic cancer	4.22e-05	0.000443	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TP53—hematologic cancer	4.09e-05	0.000428	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HRAS—hematologic cancer	3.91e-05	0.000409	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—hematologic cancer	3.74e-05	0.000392	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT1—hematologic cancer	3.45e-05	0.000362	CbGpPWpGaD
